drugset / Trial / NCT02251379

Environmental Control as Add-on Therapy in Childhood Asthma

NCT02251379

Phase 2 Completed 155 enrolled Johns Hopkins University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the effects of adding on an environmental home intervention to standard asthma medication management on controller medication requirements among children and adolescents with asthma. The investigators hypothesize that the addition of an individually-tailored, multi-faceted Environmental Control Strategy (ECS) to guidelines-based controller medication will result in less controller medication requirement and allergic inflammation than controller medication alone among urban asthmatic children.

Timeline

Start
2014-10-01
Primary completion
2018-11
Completion
2018-11

Drugs

EvaluationDrugModalityDoseRoute
Background Fluticasone propionate Other / unclassified 50 ug Inhaled
Background Fluticasone propionate Other / unclassified 100 ug Inhaled
Background Fluticasone propionate Other / unclassified 250 ug Inhaled
Background Fluticasone propionate Other / unclassified Inhaled

Indications